PROCEPT BioRobotics PE Ratio 2021-2025 | PRCT
Current and historical p/e ratio for PROCEPT BioRobotics (PRCT) from 2021 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. PROCEPT BioRobotics PE ratio as of February 12, 2026 is 0.00.
| PROCEPT BioRobotics PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2026-02-12 | 28.09 | 0.00 | |
| 2025-09-30 | 35.69 | $-1.53 | 0.00 |
| 2025-06-30 | 57.60 | $-1.55 | 0.00 |
| 2025-03-31 | 58.26 | $-1.70 | 0.00 |
| 2024-12-31 | 80.52 | $-1.76 | 0.00 |
| 2024-09-30 | 80.12 | $-1.95 | 0.00 |
| 2024-06-30 | 61.09 | $-2.06 | 0.00 |
| 2024-03-31 | 49.42 | $-2.12 | 0.00 |
| 2023-12-31 | 41.91 | $-2.24 | 0.00 |
| 2023-09-30 | 32.81 | $-2.33 | 0.00 |
| 2023-06-30 | 35.35 | $-2.33 | 0.00 |
| 2023-03-31 | 28.40 | $-2.20 | 0.00 |
| 2022-12-31 | 41.54 | $-1.96 | 0.00 |
| 2022-09-30 | 41.46 | $-1.75 | 0.00 |
| 2022-06-30 | 32.69 | $-2.46 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $1.593B | $0.225B |
| PROCEPT BioRobotics Corporation is a commercial-stage surgical robotics company. It focused on advancing patient care by developing transformative solutions in urology. The company develops, manufactures and sells the AquaBeam Robotic System, an advanced, image-guided, surgical robotic system for use in minimally-invasive urologic surgery with an initial focus on treating benign prostatic hyperplasia. PROCEPT BioRobotics Corporation is based in REDWOOD CITY, Calif. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $198.062B | 23.05 |
| Intuitive Surgical (ISRG) | United States | $176.187B | 67.96 |
| IDEXX Laboratories (IDXX) | United States | $51.802B | 49.63 |
| Edwards Lifesciences (EW) | United States | $46.035B | 30.99 |
| Alcon (ALC) | Switzerland | $39.268B | 26.46 |
| IQVIA Holdings (IQV) | United States | $30.174B | 16.30 |
| Mettler-Toledo (MTD) | United States | $28.306B | 32.55 |
| DexCom (DXCM) | United States | $26.580B | 36.64 |
| STERIS (STE) | Ireland | $23.878B | 24.15 |
| Waters (WAT) | United States | $19.603B | 25.07 |
| Coloplast (CLPBY) | Denmark | $17.488B | 26.76 |
| Hologic (HOLX) | United States | $16.763B | 17.54 |
| SONOVA HOLDING (SONVY) | Switzerland | $15.540B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $13.942B | 11.56 |
| Penumbra (PEN) | United States | $13.247B | 93.18 |
| Globus Medical (GMED) | United States | $11.813B | 24.79 |
| SARTORIUS (SSSGY) | Germany | $7.976B | 46.32 |
| Masimo (MASI) | United States | $7.254B | 23.24 |
| Sysmex ADR (SSMXY) | Japan | $6.295B | 20.00 |
| Glaukos (GKOS) | United States | $6.262B | 0.00 |
| Teleflex (TFX) | United States | $4.727B | 7.53 |
| TransMedics (TMDX) | United States | $4.555B | 53.97 |
| LivaNova (LIVN) | United Kingdom | $3.627B | 19.60 |
| Integer Holdings (ITGR) | United States | $3.055B | 14.34 |
| Veracyte (VCYT) | United States | $2.845B | 32.42 |
| Elekta AB (EKTAY) | Sweden | $2.250B | 21.05 |
| Nihon Kohden (NHNKY) | Japan | $2.036B | 22.47 |
| UFP Technologies (UFPT) | United States | $2.032B | 26.83 |
| Alphatec Holdings (ATEC) | United States | $2.001B | 0.00 |
| Artivion (AORT) | United States | $1.900B | 87.17 |
| Pulse Biosciences (PLSE) | United States | $1.711B | 0.00 |
| AxoGen (AXGN) | United States | $1.564B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.333B | 0.00 |
| IRadimed (IRMD) | United States | $1.311B | 58.90 |
| OPKO Health (OPK) | United States | $0.960B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.871B | 4.72 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.702B | 14.00 |
| SiBone (SIBN) | United States | $0.661B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.632B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.622B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.617B | 35.87 |
| Pacific Biosciences Of California (PACB) | United States | $0.556B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.535B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.504B | 13.13 |
| NeuroPace (NPCE) | United States | $0.485B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.469B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.432B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.380B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.335B | 55.88 |
| RxSight (RXST) | United States | $0.330B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.311B | 2.32 |
| Sight Sciences (SGHT) | United States | $0.292B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.286B | 0.00 |
| 908 Devices (MASS) | United States | $0.239B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.236B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.186B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.183B | 0.00 |
| Inogen (INGN) | United States | $0.166B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.165B | 0.00 |
| CVRx (CVRX) | United States | $0.159B | 0.00 |
| LENSAR (LNSR) | United States | $0.148B | 0.00 |
| Nano-X Imaging (NNOX) | Israel | $0.146B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.134B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.129B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.127B | 0.00 |
| Neuronetics (STIM) | United States | $0.123B | 0.00 |
| Hyperfine (HYPR) | United States | $0.107B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.078B | 0.00 |
| Solana (HSDT) | United States | $0.078B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.078B | 0.00 |
| DarioHealth (DRIO) | United States | $0.074B | 0.00 |
| InspireMD (NSPR) | United States | $0.073B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.067B | 0.00 |
| Positron (POSC) | United States | $0.065B | 0.00 |
| Accuray (ARAY) | United States | $0.058B | 0.00 |
| Spectral AI (MDAI) | United States | $0.047B | 0.00 |
| Precision Optics (POCI) | United States | $0.039B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.035B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.026B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.022B | 0.00 | |
| Envoy Medical (COCH) | United States | $0.019B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.016B | 0.00 |
| Check-Cap (MBAI) | Israel | $0.013B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.012B | 0.00 |
| NexGel (NXGL) | United States | $0.011B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.006B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| ENvue Medical (FEED) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |